Tailoring Melanoma Management: The Role of Gene Expression Profile Tests in Risk Stratification and Treatment
*To be eligible to attend this meeting, clinicians must be a practicing dermatologist, or advanced practitioner in dermatology in the US.
Objectives:
•Discuss the current staging systems utilized to guide melanoma and squamous cell carcinoma treatment and the limitations and challenges associated with these current systems. •Highlight the utility of gene expression profile testing to enhance risk stratification and personalize treatment decisions in melanoma and squamous cell carcinoma. •Explore how gene expression profiling might be implemented into clinical practice through case-based discussion.
MEETING DETAILS
DATE & TIME
June 19, 2025
6:00 PM - 8:00 PM PST
EVENT VENUE
Virtual
MARKET RESEARCH PARTICIPATION
Dermatology Times® — an MJH Life Sciences Brand
Copyright 2025 © Multimedia Healthcare Communications, LLC. All Rights Reserved.